As a summer wave of Covid-19 continues to hit the United States, the US Food and Drug Administration on Thursday signed off ...
The Food and Drug Administration (FDA) announced Thursday the approval of both Pfizer’s and Moderna’s updated COVID-19 ...
The Covid jabs target a strain called KP.2, a descendant of the highly contagious omicron subvariant JN.1 that began ...
US regulators approved updated versions of the Covid-19 vaccines made by Pfizer Inc. and Moderna Inc. as infections climb ...
The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including ...
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
Spikevax 2024-2025 formula expected to be available in pharmacies and care settings across the U.S. in the days immediately following approval CAMBRIDGE, MA / ACCESSWIRE / August 22, 2024 / Moderna, ...
The Food and Drug Administration on Thursday approved updated COVID-19 vaccines made by Pfizer Inc. and Moderna Inc., as a ...
There has been a summer surge in COVID cases and it does not appear to be slowing down going into the fall. Both Moderna and ...
The mRNA COVID-19 vaccines are manufactured by Pfizer-BioNTech and Moderna, who plan to have them available in a few days.
Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - R&D Day and Business Updates at 9:00 a.m. ET on Thursday, September 12, 2024.
Moderna shares lost ground even as the biotech firm received approval for its latest COVID-19 vaccine. Nordson shares ticked ...
The latest formulations of the Covid-19 vaccines made by Moderna Inc. and Pfizer Inc./BioNTech SE have been approved by the U.S. Food and Drug Administration. Here's when they will become available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results